Missoula, MTNCT07556159Now EnrollingIRB Ready

Asthma Clinical Trial in Missoula, MT

Access cutting-edge asthma treatment through this clinical trial at a research site in Missoula. Study-provided care at no cost to qualified participants.

Sponsored by Sanofi

Quick Self-Assessment

See if you qualify for this Missoula location

Preparing your pre-screening questions…

Expert Care in Missoula

Access asthma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related asthma treatment provided free

Apply for This Missoula Location

Check if you qualify for this asthma clinical trial in Missoula, MT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Missoula

    Convenient for MT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Missoula site if eligible
  4. 4Begin participation

About This Asthma Study in Missoula

The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.

Sponsor: Sanofi

Who Can Participate

Inclusion Criteria

Applicable for Part 1 participants:
Age 6 years and older, at the time of signing the informed consent
Physician diagnosis of asthma for at least 12 months
Existing treatment with low, medium, or high dose ICS and other asthma therapies as reflected in GINA 2-5 steps
Participant or legally authorized representative (where applicable) has consented to participate Applicable for Part 2 participants:
Age 18 years and older, at the time of signing the informed consent.
Physician diagnosis of asthma for at least 12 months
Existing treatment with low or medium ICS and other asthma therapies as reflected in GINA 2-4 steps
Participant or legally authorized representative (where applicable) has consented to participate
Participants must meet the criteria for at least one of the cohorts below: A) Asthma control cohorts
ACQ-5 \>= 1.5
ACQ-5 \< 1.5 (B) Type-2 biomarker cohorts
Elevated T2 biomarkers (B1: Type-2-high cohort)
Low T2 biomarkers (B2: Type-2-low cohort) Participants are excluded from the study if any of the following criteria apply (applicable for both Part 1 and Part 2 participants):
Current diagnosis of chronic obstructive pulmonary disease (COPD) or congestive heart failure
Participants with moderate/severe cognitive impairment.
Participants with moderate/severe cardiac disease.
Participants on immunosuppressive medication for a chronic condition.
Participation in other interventional and noninterventional clinical study (currently or in the past 3 months) The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Missoula?

Yes, this clinical trial (NCT07556159) has an active research site in Missoula, MT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Asthma Treatment Options in Missoula, MT

If you're searching for asthma treatment options in Missoula, MT, this clinical trial (NCT07556159) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Missoula research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all asthma clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Missoula, MT

See all ankylosing spondylitis clinical trials recruiting in Missoula — not just this study.

Browse Ankylosing Spondylitis Trials in Missoula →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsAsthma TrialsPediatric Asthma TrialsModerate-to-Severe Asthma TrialsAll Conditions →

Ready to Join in Missoula?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Missoula, MT